Search results
Results From The WOW.Com Content Network
Treatment may focus on poor posture, cervical muscle spasms and treatment for referred cervical origin (pain referred from upper levels of the cervical spine) or orofacial pain. MT has been used to restore normal range of motion, promoting circulation, stimulate proprioception , break fibrous adhesions, stimulate synovial fluid production and ...
ATC code M01 Anti-inflammatory and antirheumatic products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
This means that one drug can have more than one code, for example acetylsalicylic acid (aspirin) has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic; as well as one code can represent more than one active ingredient, for example C09BB04 is the combination of perindopril ...
In several major drug classification systems, these four types of classifications are organized into a hierarchy. [4] For example, fibrates are a chemical class of drugs (amphipathic carboxylic acids) that share the same mechanism of action ( PPAR agonist ), the same mode of action (reducing blood triglyceride levels), and are used to prevent ...
Condylar resorption, also called idiopathic condylar resorption, ICR, and condylysis, is a temporomandibular joint disorder in which one or both of the mandibular condyles are broken down in a bone resorption process.
Temporomandibular disorder (TMD, also termed "temporomandibular joint pain-dysfunction syndrome") is pain and dysfunction of the TMJ and the muscles of mastication (the muscles that move the jaw). TMD does not fit neatly into any one etiologic category since the pathophysiology is poorly understood and it represents a range of distinct ...
Pages in category "Pharmacological classification systems" The following 31 pages are in this category, out of 31 total. This list may not reflect recent changes .
Version 3.0 also included drug transporter data, drug pathway data, drug pricing, patent and manufacturing data as well as data on >5000 experimental drugs. Version 4.0 was released in 2014. [ 4 ] This version included 1558 FDA-approved small molecule drugs, 155 biotech drugs and 4200 unique drug targets.